首页> The Lancet. Respiratory medicine> Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study.

Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Nathan J,Brendish

第一单位： School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

作者： Nathan J,Brendish ^[1] ; Stephen,Poole ^[2] ; Vasanth V,Naidu ^[3] ; Christopher T,Mansbridge ^[3] ; Nicholas J,Norton ^[3] ; Helen,Wheeler ^[4] ; Laura,Presland ^[4] ; Stephen,Kidd ^[5] ; Nicholas J,Cortes ^[5] ; Florina,Borca ^[4] ; Hang,Phan ^[4] ; Gavin,Babbage ^[6] ; Benoit,Visseaux ^[7] ; Sean,Ewings ^[8] ; Tristan W,Clark ^[9]

作者单位： School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, UK. ^[1] School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, UK; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK. ^[2] Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, UK. ^[3] NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK. ^[4] Department of Microbiology, Basingstoke and North Hampshire Hospital, Hampshire Hospital NHS Foundation Trust, Basingstoke, UK. ^[5] NIHR Southampton Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UK. ^[6] Universitè de Paris, Assistance Publique-Hôpitaux de Paris, Laboratoire de Virologie, Hôpital Bichat, Paris, France. ^[7] Southampton Clinical Trials Unit, University of Southampton, Southampton, UK. ^[8] School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, UK; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK. Electronic address: t.w.clark@soton.ac.uk. ^[9]

医学主题词成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);病例对照研究(Case-Control Studies);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);疾病大流行(Pandemics);试验预期值(Predictive Value of Tests);比例危险度模型(Proportional Hazards Models);前瞻性研究(Prospective Studies);时间因素(Time Factors)

DOI 10.1016/S2213-2600(20)30454-9

PMID 33038974

发布时间 2024-08-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Lancet. Respiratory medicine

2020年8卷12期

1192-1200页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

The Lancet. Respiratory medicine

2020年8卷12期

1192-1200页

检索历史清除

Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study.

The Lancet. Respiratory medicine

相似文献

同项目论文

The Lancet. Respiratory medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study.

The Lancet. Respiratory medicine

相似文献

同项目论文

The Lancet. Respiratory medicine

相关期刊

检索历史清除